Endogenous fungal endophthalmitis: Risk factors, clinical course, and visual outcome in 13 patients

Keyphrases

• Clinical Course 100%
• Risk Factors 100%
• Course Outcomes 100%
• Endogenous Endophthalmitis 100%
• Visual Outcome 100%
• Antifungal Agents 66%
• Antifungal Therapy 66%
• Blood Culture 66%
• Ocular Complications 66%
• Intravitreal Antifungal 66%
• Inflammation 33%
• Fever 33%
• Voriconazole 33%
• Fungal Infection 33%
• Organ Transplantation 33%
• Visual Acuity 33%
• Medical Therapy 33%
• Treatment Modalities 33%
• Medical Files 33%
• Inflammatory Response 33%
• Age at Presentation 33%
• Common Complications 33%
• Uveitis 33%
• Surgical Procedures 33%
• Surgical Intervention 33%
• Ophthalmological 33%
• High Index of Suspicion 33%
• Visual Improvement 33%
• Ophthalmic Examination 33%
• Oral Steroids 33%
• Ocular Symptoms 33%
• Urological Intervention 33%
• Visual Prognosis 33%
• Maculopathy 33%
• Vitrectomized Eye 33%
• Diagnostic Vitrectomy 33%
• Intravitreal Steroids 33%
• Intravitreal Dexamethasone 33%
• Vitreous Culture 33%
• Antifungal Use 33%
• Gastrointestinal Intervention 33%
• Intravitreal Pharmacotherapies 33%

Medicine and Dentistry

• Antifungal Therapy 100%
• Disease Course 100%
• Antifungal Agent 100%
• Blood Culture 100%
• Fungal Endophthalmitis 100%
• Diagnosis 50%
• Symptom 50%
• Serositis 50%
• Surgery 50%
• Drug Therapy 50%
• Combination Therapy 50%
• Surgical Technique 50%
• Mycosis 50%
• Dexamethasone 50%
• Visual Acuity 50%
• Organ Transplantation 50%
• Vitrectomy 50%
• Vitreous 50%
• Uveitis 50%
• Maculopathy 50%
• Voriconazole 50%